Abstract
There is evidence that predisposition to cancer has a genetic component. Genetic models have suggested that there is at least one highly penetrant gene predisposing to this disease. The oncogene MXI1 on chromosome band 10q24-25 is mutated in a proportion of prostate tumours and loss of heterozygosity occurs at this site, suggesting the location of a tumour suppressor in this region. To investigate the possibility that MXI1 may be involved in inherited susceptibility to prostate cancer, we have sequenced the HLH and ZIP regions of the gene in 38 families with either three cases of prostate cancer or two affected siblings both diagnosed below the age of 67 years. These are the areas within which mutations have been described in some sporadic prostate cancers. No mutations were found in these two important coding regions and we therefore conclude that MXI1 does not make a major contribution to prostate cancer susceptibility.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Edwards, S., Dearnaley, D., Ardern-Jones, A. et al. No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. Br J Cancer 76, 992–1000 (1997). https://doi.org/10.1038/bjc.1997.498
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.498
This article is cited by
-
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
British Journal of Cancer (2014)
-
Germline BRCA1 mutations increase prostate cancer risk
British Journal of Cancer (2012)
-
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
British Journal of Cancer (2011)
-
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
British Journal of Cancer (2010)
-
ATM polymorphisms as risk factors for prostate cancer development
British Journal of Cancer (2004)